1760 — Panion & BF Biotech Share Price
0.000.00%
Last trade - 00:00- TWD5.80bn
- TWD5.95bn
- TWD2.03bn
- 82
- 25
- 33
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.99 | ||
| Price to Tang. Book | 3 | ||
| Price to Free Cashflow | 34.71 | ||
| Price to Sales | 2.83 | ||
| EV to EBITDA | 15.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.43% | ||
| Return on Equity | 6.5% | ||
| Operating Margin | 10.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 1,568.64 | 1,901.21 | 2,398.65 | 1,881.88 | 2,029.64 | 2,229 | n/a | 5.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -83.34 | +270.87 | +57.76 | -56.72 | +60.96 | +21.21 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PANION & BF BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of western medicines and experimental drugs. The Company is also involved in the manufacture and sales of various kinds of cosmetics. The Company's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The Company also provides biotechnology services. The Company distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.
Directors
- Li Chiu Chang CHM
- Chung Ming Chiang GMG
- Wenting Ke DGM
- Junping Lu DGM
- Fengren Wang DGM
- Chongqi Cai DRC
- Weng-Foung Huang DRC
- Zhiming Lin DRC
- Defu Xie DRC
- Junda Zheng DRC
- Ryh-Yan Chang IND
- Jinxuan Chen IND
- Jizhou Liao IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 7th, 1976
- Public Since
- June 14th, 2004
- No. of Employees
- 321
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 85,739,000
- Address
- 16F, Building F, TAIPEI, 115
- Web
- https://www.pbf.com.tw/
- Phone
- +886 226558218
- Contact
- Chung-Chi Tsai
- Auditors
- KPMG LLP
Upcoming Events for 1760
Panion & BF Biotech Inc Annual Shareholders Meeting
Panion & BF Biotech Inc Annual Shareholders Meeting
Q2 2025 Panion & BF Biotech Inc Earnings Release
Similar to 1760
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
BRIM Biotechnology
Taiwan Stock Exchange
Caliway Biopharmaceuticals Co
Taiwan Stock Exchange
Cenra
Taiwan Stock Exchange
FAQ
What is the Panion & BF Biotech share price?
As of Today at 22:34 UTC, shares in Panion & BF Biotech are trading at TWD67.00. This share price information is delayed by 15 minutes.
How has the Panion & BF Biotech share price performed this year?
Shares in Panion & BF Biotech last closed at TWD67.00 and the price had moved by -31% over the past 365 days. In terms of relative price strength the Panion & BF Biotech share price has underperformed the FTSE Developed Asia Pacific Index by -30.21% over the past year.
What are the analyst and broker recommendations for Panion & BF Biotech?
The overall consensus recommendation for Panion & BF Biotech is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Panion & BF Biotech dividend yield?
The Panion & BF Biotech dividend yield is 2.69% based on the trailing twelve month period.
Does Panion & BF Biotech pay a dividend?
Last year, Panion & BF Biotech paid a total dividend of TWD1.80, and it currently has a trailing dividend yield of 2.69%. We do not have any data on when Panion & BF Biotech is to next pay dividends.
When does Panion & BF Biotech next pay dividends?
We do not have data on when Panion & BF Biotech is to next pay dividends. The historic dividend yield on Panion & BF Biotech shares is currently 2.69%.
How do I buy Panion & BF Biotech shares?
To buy shares in Panion & BF Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Panion & BF Biotech?
As of the previous close price of TWD67.00, shares in Panion & BF Biotech had a market capitalisation of TWD5.80bn.
Where are Panion & BF Biotech shares listed?
Here are the trading details for Panion & BF Biotech:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 1760
What kind of share is Panion & BF Biotech?
Based on an overall assessment of its quality, value and momentum Panion & BF Biotech is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Panion & BF Biotech share price forecast for 2025?
The analyst consensus target price for shares in Panion & BF Biotech is TWD106.39. That is 58.79% above the last closing price of TWD67.00.
Analysts covering Panion & BF Biotech currently have a consensus Earnings Per Share (EPS) forecast of TWD1.76 for the next financial year.
Find out moreWhat is the trend in the Panion & BF Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Panion & BF Biotech. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -18.11%.
As of the last closing price of TWD67.00, shares in Panion & BF Biotech were trading -22.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Panion & BF Biotech PE Ratio?
The Panion & BF Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD67.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Panion & BF Biotech?
Panion & BF Biotech's management team is headed by:
- Li Chiu Chang - CHM
- Chung Ming Chiang - GMG
- Wenting Ke - DGM
- Junping Lu - DGM
- Fengren Wang - DGM
- Chongqi Cai - DRC
- Weng-Foung Huang - DRC
- Zhiming Lin - DRC
- Defu Xie - DRC
- Junda Zheng - DRC
- Ryh-Yan Chang - IND
- Jinxuan Chen - IND
- Jizhou Liao - IND